Blood is the currency of clinical trials—and getting it from patient to lab within 48 hours can make or break a study. In this episode, LabConnect CEO Wes Wheeler joins us to discuss how a lab-agnostic model, purpose-built software, and disciplined process design are transforming global clinical research. Wes breaks down why LabConnect chooses not to own labs and how this decision enables speed, scale, and flexibility across seven key regions where trials are conducted and patients resi...
All content for Tomorrow’s World Today® Podcast is the property of Tomorrow's World Today® and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Blood is the currency of clinical trials—and getting it from patient to lab within 48 hours can make or break a study. In this episode, LabConnect CEO Wes Wheeler joins us to discuss how a lab-agnostic model, purpose-built software, and disciplined process design are transforming global clinical research. Wes breaks down why LabConnect chooses not to own labs and how this decision enables speed, scale, and flexibility across seven key regions where trials are conducted and patients resi...
Botanical Breakthroughs: How New Chapter’s Natural Approach is Rooted in Wellness
Tomorrow’s World Today® Podcast
28 minutes
6 months ago
Botanical Breakthroughs: How New Chapter’s Natural Approach is Rooted in Wellness
From plants to people, Charlotte Traas, former Director of Education at New Chapter, shares her story of creating groundbreaking products that bring nature’s power to everyday health. 🌱 Featured on: Tomorrow's World Today - S3E07 – Internal Health of TomorrowTomorrow's World Today - S4E13 – The Science Behind SupplementsLearn more about this topic: Why Do I Need Fermented Supplements?What is Regenerative Agriculture?Benefits of Fermented Foods5 Ways To Boost Your Kid’s ImmunityCollaborate wit...
Tomorrow’s World Today® Podcast
Blood is the currency of clinical trials—and getting it from patient to lab within 48 hours can make or break a study. In this episode, LabConnect CEO Wes Wheeler joins us to discuss how a lab-agnostic model, purpose-built software, and disciplined process design are transforming global clinical research. Wes breaks down why LabConnect chooses not to own labs and how this decision enables speed, scale, and flexibility across seven key regions where trials are conducted and patients resi...
